Public Citizen is pushing the FDA to take Crestor (rosuvastatin) off the market

April 2004

The consumer group, Public Citizen, is pushing the FDA to take Crestor (rosuvastatin) off the market.

They say that rates of renal failure and rhabdo are too high.

Public Citizen has a track record worth noting. They successfully went after phenylpropanolamine, Rezulin, Trovan.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote